Multiplatform metabolomics reveals novel serum metabolite biomarkers in diabetic retinopathy subjects

Q Xuan, Y Ouyang, Y Wang, L Wu, H Li… - Advanced …, 2020 - Wiley Online Library
Diabetic retinopathy (DR) is the main cause of vision loss or blindness in working age adults
worldwide. The lack of effective diagnostic biomarkers for DR leads to unsatisfactory curative …

Metabolomics in diabetic retinopathy: from potential biomarkers to molecular basis of oxidative stress

Q Jian, Y Wu, F Zhang - Cells, 2022 - mdpi.com
Diabetic retinopathy (DR), the leading cause of blindness in working-age adults, is one of
the most common complications of diabetes mellitus (DM) featured by metabolic disorders …

Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients

JH Yun, JM Kim, HJ Jeon, T Oh, HJ Choi, BJ Kim - PLoS One, 2020 - journals.plos.org
Diabetic retinopathy (DR) is a common complication of diabetes, and it is the consequence
of microvascular retinal changes due to high glucose levels over a long time. Metabolomics …

Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy

X Du, L Yang, L Kong, Y Sun, K Shen, Y Cai… - Frontiers in …, 2022 - frontiersin.org
Diabetic retinopathy (DR) is a universal microvascular complication of diabetes mellitus
(DM), which is the main reason for global sight damage/loss in middle-aged and/or older …

[HTML][HTML] Metabolomics in diabetic retinopathy: a systematic review

XW Hou, Y Wang, CW Pan - Investigative ophthalmology & …, 2021 - tvst.arvojournals.org
Purpose: Diabetic retinopathy (DR), a common microvascular complication of diabetes, is
the leading cause of acquired blindness in the working-age population. Individuals with …

Plasma metabolomics reveals metabolic profiling for diabetic retinopathy and disease progression

Y Sun, H Zou, X Li, S Xu, C Liu - Frontiers in Endocrinology, 2021 - frontiersin.org
Backgrounds Diabetic retinopathy (DR), the main retinal vascular complication of DM, is the
leading cause of visual impairment and blindness among working-age people worldwide …

Metabolites as risk factors for diabetic retinopathy in patients with type 2 diabetes: a 12-year follow-up study

L Fernandes Silva, J Hokkanen… - The Journal of …, 2024 - academic.oup.com
Context Diabetic retinopathy (DR) is a specific microvascular complication in patients with
diabetes and the leading cause of blindness. Recent advances in omics, especially …

Plasma metabolomic profiling of proliferative diabetic retinopathy

XR Zhu, F Yang, J Lu, H Zhang, R Sun, JB Zhou… - Nutrition & …, 2019 - Springer
Background Proliferative diabetic retinopathy (PDR), a sight-threatening retinopathy, is the
leading cause of irreversible blindness in adults. Despite strict control of systemic risk …

Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus

J Zuo, Y Lan, H Hu, X Hou, J Li, T Wang… - BMJ Open Diabetes …, 2021 - drc.bmj.com
Introduction Despite advances in diabetic retinopathy (DR) medications, early identification
is vitally important for DR administration and remains a major challenge. This study aims to …

Metabolomics study of diabetic retinopathy using gas chromatography–mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese …

X Li, X Luo, X Lu, J Duan, G Xu - Molecular BioSystems, 2011 - pubs.rsc.org
Diabetic retinopathy (DR) is a serious microvascular syndrome of diabetes, and is one of the
most frequent causes of blindness in the world. It has three progressive stages with complex …